Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial

Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial

Abstract Background Metformin has favorable effects on cardiovascular outcomes in both newly onset and advanced type 2 diabetes, as previously reported findings from the UK Prospective Diabetes Study and the HOME trial have demonstrated. Patients with type 2 diabetes present with chronically elevate...

Full description

Bibliographic Details
Main Authors: Johanna M. G. Stultiens, Wiebe M. C. Top, Dorien M. Kimenai, Philippe Lehert, Otto Bekers, Coen D. A. Stehouwer, Adriaan Kooy, Steven J. R. Meex
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Cardiovascular Diabetology
Subjects:
Metformin
Troponin
Cardiac
Biomarker
Longitudinal
Cardioprotective
Online Access:https://doi.org/10.1186/s12933-022-01482-z

Internet

https://doi.org/10.1186/s12933-022-01482-z

Similar Items